LAC Med Berhad (KLSE:LACMED)
Malaysia · Delayed Price · Currency is MYR 0.7000
-0.0150 (-2.10%)
At close: Jun 9, 2026
LAC Med Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 17.98 | 21.99 | 20.4 | 20.74 | 13.06 |
Depreciation & Amortization | 1.94 | 1.29 | 0.39 | 0.29 | 0.18 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | - | - | - |
Asset Writedown & Restructuring Costs | 0 | 0 | 0.01 | 0 | - |
Provision & Write-off of Bad Debts | 0.06 | 0.67 | 0.32 | -2.11 | 1.55 |
Other Operating Activities | -0.85 | 3.09 | 5.52 | 6.25 | 3.31 |
Change in Accounts Receivable | -42.29 | -28.29 | 17.63 | -15.07 | -9.63 |
Change in Inventory | -7.8 | -7.06 | 0.74 | -10.48 | -1.47 |
Change in Accounts Payable | 14.52 | 10.18 | -10.95 | 17.87 | -11.93 |
Change in Unearned Revenue | -1.25 | -6.49 | -2.39 | 4.14 | 7.77 |
Change in Other Net Operating Assets | 2.71 | 5.03 | -1 | 0.98 | 0.02 |
Operating Cash Flow | -15.73 | 0.38 | 30.67 | 22.61 | 2.87 |
Operating Cash Flow Growth | - | -98.77% | 35.64% | 687.29% | - |
Capital Expenditures | -11.48 | -9.46 | -0.5 | -0.89 | -0.23 |
Cash Acquisitions | 0.3 | 0.3 | - | - | - |
Sale (Purchase) of Intangibles | -2.92 | -2.92 | - | - | - |
Investment in Securities | 8.1 | 8.48 | -10 | - | - |
Other Investing Activities | 1.07 | 2.23 | 1.7 | -0.35 | 0.5 |
Investing Cash Flow | -4.93 | -1.37 | -8.8 | -1.25 | 0.27 |
Short-Term Debt Issued | - | 65.2 | 49.76 | 58.39 | 58.49 |
Long-Term Debt Issued | - | 9.81 | 7.39 | - | - |
Total Debt Issued | 70.56 | 75.02 | 57.15 | 58.39 | 58.49 |
Short-Term Debt Repaid | - | -42.42 | -50.53 | -67.2 | -44.62 |
Long-Term Debt Repaid | - | -25.8 | -11.87 | -0.91 | -0.85 |
Total Debt Repaid | -58.27 | -68.22 | -62.4 | -68.11 | -45.47 |
Net Debt Issued (Repaid) | 12.29 | 6.8 | -5.25 | -9.73 | 13.02 |
Issuance of Common Stock | 55.65 | 55.65 | 0 | - | - |
Common Dividends Paid | -5 | -5 | -18.5 | -4 | -3.4 |
Other Financing Activities | -4.74 | -5.36 | -0.44 | -1.01 | -0.83 |
Financing Cash Flow | 58.2 | 52.08 | -24.19 | -14.74 | 8.79 |
Foreign Exchange Rate Adjustments | -0.21 | -0.28 | - | - | - |
Net Cash Flow | 37.33 | 50.81 | -2.32 | 6.63 | 11.93 |
Free Cash Flow | -27.22 | -9.09 | 30.17 | 21.72 | 2.65 |
Free Cash Flow Growth | - | - | 38.92% | 721.01% | - |
Free Cash Flow Margin | -14.83% | -4.51% | 16.47% | 14.45% | 2.48% |
Free Cash Flow Per Share | -0.13 | -0.08 | 15.09 | 10.86 | 1.32 |
Cash Interest Paid | 0.78 | 0.72 | 0.44 | 1.01 | 0.83 |
Cash Income Tax Paid | 10.2 | 7.65 | 6.92 | 5.61 | 4.58 |
Levered Free Cash Flow | -28.38 | -15.53 | 24.46 | 19.92 | - |
Unlevered Free Cash Flow | -27.65 | -15.05 | 24.77 | 20.56 | - |
Change in Working Capital | -34.11 | -26.63 | 4.03 | -2.56 | -15.23 |